-
EP2557921
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2557921
| EP2557921 - METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.07.2014 Database last updated on 06.07.2024 | Most recent event Tooltip | 25.07.2014 | Application deemed to be withdrawn | published on 27.08.2014 [2014/35] | Applicant(s) | For all designated states Johns Hopkins University Johns Hopkins Technology Transfer 100 North Charles Street, 5th Floor Baltimore, MD 21201 / US | For all designated states The University of Chicago Office Of Technology And Intellectual Property Edelstone Center 6030 S. Ellis Avenue, 2S Chicago, IL 60637 / US | For all designated states Sova Pharmaceuticals, Inc. 11099 North Torrey Pines Road Suite 290 La Jolla, CA 92037 / US | [2013/08] | Inventor(s) | 01 /
SNYDER, Solomon, H. 3801 Canterbury Road, No. 1102 Baltimore, MD 21218 / US | 02 /
GADALLA, Moataz, M. 501 Saint Paul Street, Apr. No. 1010 Baltimore, MD 21202 / US | 03 /
PRABHAKAR, Nanduri, R. 5230 S. University Avenue, Unit H Chicago, IL 60615 / US | 04 /
STEIN, Gregory 3790 Quarter Mile Drive San Diego, CA 92130 / US | 05 /
PACE, Gary 1405 Inspiration Drive La Jolla, CA 92037 / US | [2013/08] | Representative(s) | Blance, Stephen John, et al Avidity IP Broers Building Hauser Forum 21 JJ Thomson Ave Cambridge CB3 0FA / GB | [N/P] |
| Former [2013/08] | Blance, Stephen John, et al Avidity IP Merlin House Falconry Court Baker's Lane Epping, Essex CM16 5DQ / GB | Application number, filing date | 11769384.6 | 11.04.2011 | WO2011US31977 | Priority number, date | US20100347069P | 21.05.2010 Original published format: US 347069 P | US20100323621P | 13.04.2010 Original published format: US 323621 P | [2013/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011130181 | Date: | 20.10.2011 | Language: | EN | [2011/42] | Type: | A1 Application with search report | No.: | EP2557921 | Date: | 20.02.2013 | Language: | EN | The application published by WIPO in one of the EPO official languages on 20.10.2011 takes the place of the publication of the European patent application. | [2013/08] | Search report(s) | International search report - published on: | US | 20.10.2011 | (Supplementary) European search report - dispatched on: | EP | 02.07.2013 | Classification | IPC: | A01N43/16, A61K31/165, A61K31/385, A61K31/409, A61K31/4178, A61K31/519, A61K45/06, A61K31/198, A61K31/24, A61K31/28, A61K31/404, A61K31/4164, A61P11/00 | [2013/31] | CPC: |
A61K31/519 (EP,US);
A61K31/165 (EP,US);
A61K31/198 (US);
A61K31/24 (US);
A61K31/28 (US);
A61K31/385 (EP,US);
A61K31/404 (US);
A61K31/409 (EP,US);
A61K31/4164 (US);
A61K31/4178 (EP,US);
A61K45/06 (EP,US);
A61P11/00 (EP);
A61P11/16 (EP)
(-)
| C-Set: |
A61K31/165, A61K2300/00 (EP,US);
A61K31/385, A61K2300/00 (US,EP);
A61K31/409, A61K2300/00 (US,EP);
A61K31/4178, A61K2300/00 (US,EP); |
| Former IPC [2013/08] | A01N43/16 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/08] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON WÄHREND DES SCHLAFENS AUFTRETENDEN ATEMSTÖRUNGEN | [2013/08] | English: | METHODS FOR TREATMENT OF SLEEP-RELATED BREATHING DISORDERS | [2013/08] | French: | MÉTHODES DE TRAITEMENT DE TROUBLES DE RESPIRATION LIÉS AU SOMMEIL | [2013/08] | Entry into regional phase | 09.11.2012 | National basic fee paid | 09.11.2012 | Search fee paid | 09.11.2012 | Designation fee(s) paid | 09.11.2012 | Examination fee paid | Examination procedure | 09.11.2012 | Examination requested [2013/08] | 31.05.2013 | Amendment by applicant (claims and/or description) | 04.06.2013 | Application deemed to be withdrawn, date of legal effect [2014/35] | 10.03.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time [2014/35] | Fees paid | Renewal fee | 12.04.2013 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.04.2014 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US6331536 (RADULOVACKI MIODRAG [US], et al) [X] 1-5,7-9,11,12,15 * columns 18,19; claims 1-3,10-13 * * column 5, line 6 - line 9 * [I] 13,14; | [X]WO2010010383 (ISIS INNOVATION [GB], et al) [X] 1-6,15 * pages 60,61; claims 9-11,15 * * page 6, lines 25-28 *; | [X] - MUZAFFAR S ET AL, "H2S-donating sildenafil (ACS6) inhibits superoxide formation and gp91phox expression in arterial endothelial cells: role of protein kinases A and G", BRITISH JOURNAL OF PHARMACOLOGY, NATURE PUBLISHING GROUP, BASINGSTOKE, HANTS; GB, vol. 155, doi:10.1038/BJP.2008.326, ISSN 0007-1188, (20080901), pages 984 - 994, (20080901), XP002509335 [X] 1,3-5,7-10 * abstract * DOI: http://dx.doi.org/10.1038/BJP.2008.326 | [A] - QIAN LI ET AL, "A Crucial Role for Hydrogen Sulfide in Oxygen Sensing via Modulating Large Conductance Calcium-Activated Potassium Channels", ANTIOXIDANTS AND REDOX SIGNALING, MARY ANN LIEBERT, LARCHMONT, NY, US, vol. 12, no. 10, doi:10.1089/ARS.2009.2926, ISSN 1523-0864, (20100412), pages 1179 - 1189, (20100203), XP008162278 [A] 1,3-6 * page 1179 - page 1180 * * page 1183, column right, paragraph 2nd - page 1187 * DOI: http://dx.doi.org/10.1089/ars.2009.2926 | [A] - JOHN L WALLACE ET AL, "Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)", BRITISH JOURNAL OF PHARMACOLOGY, NATURE PUBLISHING GROUP, BASINGSTOKE, HANTS; GB, vol. 159, no. 6, doi:10.1111/J.1476-5381.2009.00611.X, ISSN 0007-1188, (20100301), pages 1236 - 1246, (20100201), XP008162275 [A] 1,7-10 * page 1237; figure 1 * DOI: http://dx.doi.org/10.1111/j.1476-5381.2009.00611.x | International search | [X]US6331536 (RADULOVACKI MIODRAG [US], et al); | [X] - LI ET AL., "A Crucial Role for Hydrogen Sulfide in Oxygen Sensing via Modulating Large Conductance Calcium-Activated Potassium Channels", ANTIOXIDANTS AND REDOX SIGNALLING, (20100203), vol. 12, no. 10, pages 1179 - 1189, XP008162278 DOI: http://dx.doi.org/10.1089/ars.2009.2926 | [Y] - KINOBE ET AL., "Inhibitors of the heme oxygenase - carbon monoxide system: on the doorstep of the clinic", CANADIAN JOUMAL OF PHYSIOLOGY AND PHARMACOLOGY, (2008), vol. 86, pages 577 - 599, XP008162295 DOI: http://dx.doi.org/10.1139/Y08-066 | [Y] - PRABHAKAR ET AL., "Carbon monoxide: A role in carotid body chemoreception", PROCEEDINGS FROM THE NATIONAL ACADEMY SCIENCE, (1995), vol. 92, pages 1994 - 1997, XP008162276 DOI: http://dx.doi.org/10.1073/pnas.92.6.1994 | [Y] - WALLACE ET AL., "Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)", BRITISH JOUMAL OF PHARMACOLOGY, (20100201), vol. 159, pages 1236 - 1246, XP008162275 DOI: http://dx.doi.org/10.1111/j.1476-5381.2009.00611.x |